Author

ASHOK BHANDARI 1

1 PROTAGONIST THERAPEUTICS, CHEMISTRY, Milpitas, United States of America

PHARMACOKINETICS AND PHARMACODYNAMICS FOLLOWING ORAL ADMINISTRATION OF PTG-100, A PEPTIDE ANTAGONIST OF INTEGRIN ?4?7

Thamilarasi Annamalai, Larry Mattheakis, ASHOK BHANDARI, David Liu, Genet Zemede, Sarah Hadley, Li Zhao, NAMITHA RAO

SAFETY, PHARMACOKINETICS AND PHARMACODYNAMICS OF THE NOVEL ORAL PEPTIDE THERAPEUTIC PTG-100 (ALPHA4-BETA7 INTEGRIN ANTAGONIST) IN NORMAL HEALTHY VOLUNTEERS

Richard Shames, Lucio Tozzi, Larry Mattheakis, THAMIL ANNAMALAI, ASHOK BHANDARI, David Liu

Safety, Tolerability, and Pharmacokinetics of PTG-200, An Oral GI-restricted Peptide Antagonist of IL-23 Receptor, In Normal Healthy Volunteers

Lili Xiaoli Cheng, Tien-Yi Lee, Grace Ledet, James Tovera, Robert Campbell, Norbert Purro, THAMIL ANNAMALAI, ASHOK BHANDARI, Mohammad Masjedizadeh, David Liu, Roya Nawabi, Bittoo Kenwar

Item 1 - 3 / 3
1